
Zhejiang XinNong Chemical Co.,Ltd.
SZSE:002942.SZ
17 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 962.267 | 821.032 | 1,248.167 | 1,162.571 | 1,193.675 | 1,086.084 | 966.953 | 808.332 | 599.358 | 536.975 | 538.585 | 532.985 | 558.108 |
Cost of Revenue
| 697.068 | 640.435 | 929.474 | 806.746 | 826.024 | 749.009 | 659.328 | 570.145 | 444.945 | 389.342 | 392.817 | 393.893 | 414.179 |
Gross Profit
| 265.199 | 180.598 | 318.693 | 355.825 | 367.651 | 337.075 | 307.625 | 238.187 | 154.412 | 147.633 | 145.767 | 139.092 | 143.929 |
Gross Profit Ratio
| 0.276 | 0.22 | 0.255 | 0.306 | 0.308 | 0.31 | 0.318 | 0.295 | 0.258 | 0.275 | 0.271 | 0.261 | 0.258 |
Reseach & Development Expenses
| 52.583 | 58.329 | 70.238 | 75.723 | 62.38 | 50.259 | 48.263 | 34.504 | 30.297 | 29.378 | 21.087 | 0 | 20.439 |
General & Administrative Expenses
| 18.251 | 29.725 | 17.859 | 26.274 | 20.083 | 22.846 | 20.526 | 16.906 | 15.211 | 16.234 | 18.197 | 59.563 | 57.558 |
Selling & Marketing Expenses
| 26.807 | 25.77 | 57.521 | 58.336 | 45.56 | 57.167 | 53.094 | 45.834 | 39.145 | 30.668 | 31.392 | 29.434 | 30.117 |
SG&A
| 45.058 | 55.495 | 75.379 | 84.61 | 65.642 | 80.014 | 73.62 | 62.74 | 54.356 | 46.902 | 49.589 | 88.997 | 87.676 |
Other Expenses
| 102.972 | 96.344 | 71.632 | 58.183 | 48.37 | 38.245 | 0.492 | 2.236 | 5.712 | 1.271 | 136.85 | 3.374 | 1.695 |
Operating Expenses
| 204.846 | 210.168 | 217.249 | 218.516 | 176.392 | 168.518 | 152.727 | 128.866 | 115.295 | 105.577 | 97.783 | 90.79 | 89.904 |
Operating Income
| 60.353 | -47.543 | 110.151 | 154.208 | 201.003 | 177.915 | 152.989 | 90.596 | 38.137 | 43.309 | 38.166 | 46.513 | 46.766 |
Operating Income Ratio
| 0.063 | -0.058 | 0.088 | 0.133 | 0.168 | 0.164 | 0.158 | 0.112 | 0.064 | 0.081 | 0.071 | 0.087 | 0.084 |
Total Other Income Expenses Net
| 2.144 | 17.184 | -0.116 | -1.043 | -2.599 | 0.941 | -0.139 | 2.236 | 5.712 | 1.271 | 136.584 | 3.374 | -5.563 |
Income Before Tax
| 62.498 | -30.359 | 110.035 | 153.165 | 198.404 | 178.856 | 152.85 | 92.832 | 43.849 | 44.579 | 174.751 | 49.887 | 48.462 |
Income Before Tax Ratio
| 0.065 | -0.037 | 0.088 | 0.132 | 0.166 | 0.165 | 0.158 | 0.115 | 0.073 | 0.083 | 0.324 | 0.094 | 0.087 |
Income Tax Expense
| 4.77 | -4.985 | 8.625 | 15.291 | 23.162 | 24.331 | 24.747 | 16.815 | 4.979 | 6.993 | 27.627 | 6.913 | 10.181 |
Net Income
| 57.728 | -25.374 | 101.397 | 137.874 | 175.242 | 154.525 | 128.102 | 76.017 | 38.869 | 37.587 | 147.123 | 43.034 | 38.412 |
Net Income Ratio
| 0.06 | -0.031 | 0.081 | 0.119 | 0.147 | 0.142 | 0.132 | 0.094 | 0.065 | 0.07 | 0.273 | 0.081 | 0.069 |
EPS
| 0.38 | -0.17 | 0.66 | 0.9 | 1.12 | 0.99 | 1.06 | 0.65 | 0.33 | 0.32 | 1.25 | 0.55 | 0.49 |
EPS Diluted
| 0.38 | -0.17 | 0.66 | 0.9 | 1.12 | 0.99 | 1.06 | 0.65 | 0.33 | 0.32 | 1.25 | 0.55 | 0.49 |
EBITDA
| 115.957 | 22.145 | 159.15 | 198.861 | 234.11 | 206.574 | 179.362 | 118.444 | 67.853 | 66.326 | 197.321 | 66.49 | 71.977 |
EBITDA Ratio
| 0.121 | 0.027 | 0.128 | 0.171 | 0.196 | 0.19 | 0.185 | 0.147 | 0.113 | 0.124 | 0.366 | 0.125 | 0.129 |